The most common type of liver cancer in children, hepatoblastoma, surprisingly appears to contain many immune cells from a type that has long been overlooked. This is according to a study by ...

MRI plus CT does not reliably predict nonviability of disappearing colorectal liver metastases, a new study reports.

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly.

Glypican-3 (GPC3) has emerged as a promising immunotherapeutic target for hepatocellular carcinoma (HCC). However, its ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

Hepatocellular carcinomas (HCCs) are challenging to diagnose due to the tumor heterogeneity and unnoticeable early symptoms. Researchers from Anhui Medical University have developed a novel gallium 68 ...

Mayo Clinic researchers have discovered a genetic factor that may explain why some colorectal cancer patients experience ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Liver cancer is one of the fastest growing causes of cancer deaths in Australia. While some risk factors can't be changed, ...

A new international study led by Mayo Clinic researchers has identified a genetic factor that may explain why some patients ...

Medical experts say vaccination is the best prevention method for hepatitis B, a liver infection that can be acute or chronic ...